6550--Butler VA Healthcare Clinic Brand Name Only Requirement Bio-Rad Immunoassay QC Materials
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 4, has issued a Pre-Solicitation Notice for a brand name only Bio-Rad immunoassay QC materials requirement for the Butler VA Healthcare Clinic located at 353 North Duffy Road, Butler, PA 16001. The full solicitation, anticipated to be unrestricted, is expected to be posted on SAM.gov on or about April 17, 2026, with responses due by April 24, 2026.
Scope of Work
This requirement is for Quality Control (QC) materials to validate laboratory instruments at the Abie Abraham VA Healthcare Center. The contractor will provide specific brand name Bio-Rad QC Materials, which must be compatible with current analyzers to ensure accurate patient results and meet laboratory quality control mandates. Key materials include various Bio-Rad Card MKR LT Plus, Multiqual Unassay, Liquichek Ethanol/Ammonia Control, Urine Chemistry, Specialty IA plus Liquid TriLv, Specialty IA Liq, U Tox Controls, and Liquichek Immunology products, with estimated quantities. Materials are to be shipped with the longest possible outdates (preferably one year from expiration) on the same lot number, scheduled based on Core Lab needs, and delivered within three business days of order placement to the dock area during normal business hours.
Contract & Timeline
- Type: Firm-Fixed-Price contract
- Duration: Five-year ordering period, including a Base Year (May 4, 2026 - May 3, 2027) and four Option Years (May 4, 2027 - May 3, 2031).
- Estimated Value: $219,461.31
- Set-Aside: Unrestricted (due to lack of competition and not meeting SBA or VA Rule of Two)
- NAICS: 325413 - In-Vitro Diagnostic Substance Manufacturing
- Size Standard: $1250 Employees
- Full Solicitation Posted: On or about April 17, 2026
- Response Due: April 24, 2026
- Published: April 17, 2026
Submission & Evaluation
This is a pre-solicitation notice and not a request for competitive offers. Potential offerors are responsible for monitoring www.sam.gov for the release of the full solicitation package and any amendments. All questions must be submitted in writing to the Contracting Officer, Keri Hester, at keri.hester1@va.gov; telephone inquiries will not be accepted. All interested parties must be registered in the System for Award Management (SAM) prior to award.
Additional Notes
The contractor will not have access to Protected Patient Health Information (PHI), VA computers, or online VA/U.S. government resources. All deliverables will be the property of the U.S. Government, and the contractor must comply with Federal and Agency records management policies.